- Home
- NCEL vs SCNX Comparison
NCEL vs SCNX Comparison
Compare NCEL & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCEL | SCNX |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 24.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NCEL | SCNX |
|---|---|---|
| Price | $2.59 | $0.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 90.9K | ★ 1.7M |
| Earning Date | 12-01-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $653,391.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 207.88 |
| 52 Week Low | $2.48 | $0.46 |
| 52 Week High | $7.64 | $8.19 |
Technical Indicators
Market Signals| Indicator | NCEL | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.76 |
| Support Level | N/A | $0.49 |
| Resistance Level | N/A | $0.60 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 15.46 |
Price Performance
Historical ComparisonAbout NCEL NewcelX Ltd. Ordinary Shares
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.